Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca discloses novel Janus kinase inhibitors

April 23, 2010

Merck Serono claims novel PI3K inhibitors

April 23, 2010

NeoPharm starts enrollment in phase II LE-DT trial in pancreatic cancer

April 22, 2010

EMA's COMP notifies CytRX of positive opinion on bafetinib in CML

April 22, 2010

Novel photosensitizer porphyrins discovered at CeramOptec

April 22, 2010

EMA recommends Cell Therapeutics submit revised PIP for pixantrone

April 22, 2010

Cheminpharma presents preclinical data on new MEK 1 inhibitor

April 22, 2010

Dual PI3K-alpha/mTOR inhibitors discovered by Pfizer

April 22, 2010

EntreMed completes registered direct offering to fund clinical development of ENMD-2076

April 21, 2010

Cornerstone receives FDA clearance for phase I trial of CPI-613 in hematologic malignancies

April 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...